CHI's Structure-Based Drug Design Conference

Cambridge Healthtech Institute’s Eleventh Annual Structure-Based Drug Design conference brings to focus the latest development in computational technology for drug discovery, and puts structure-based molecular approaches into the perspective of targeted therapeutics.

Conference Highlights: 

• Protein Flexibility
• Fully Synthetic Protein-Protein Interaction Inhibitor
• Fragment-to-Lead Optimization
• High Performance Computing and Collaborative Drug Design
• State-of-the-Art Molecular Dynamics Simulations

Keynote Speaker: 

Millisecond-Long Molecular Dynamics Simulations of Proteins on a Special-Purpose Machine

David E. Shaw, Ph.D., Chief Scientist, D. E. Shaw Research

David E. Shaw serves as chief scientist of D. E. Shaw Research and as a senior research fellow at the Center for Computational Biology and Bioinformatics at Columbia University. He received his Ph.D. from Stanford University in 1980, served on the faculty of the Computer Science Department at Columbia until 1986, and founded the D. E. Shaw group in 1988. Since 2001, Dr. Shaw has devoted most of his time to hands-on research in the field of computational biochemistry. His lab is currently involved in the development of new algorithms and machine architectures for high-speed molecular dynamics simulations of biological macromolecules, and in the application of such simulations to basic scientific research and computer-assisted drug design.

Dr. Shaw was appointed to the President’s Council of Advisors on Science and Technology by President Clinton in 1994, and again by President Obama in 2009. He is a fellow of the American Academy of Arts and Sciences and of the American Association for the Advancement of Science.

Anton: Molecular Dynamics Simulation for Drug Design 

Dinner Short Course: 

June 8, 2011

Identification of Druggable Sites for Protein-Protein Interaction Targets 

Co-Located With:
Next-Gen Kinase Inhibitors